Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YHD001 in partially controlled asthma
NCT01424124Phase 2Completed
- Sponsor
- Yuhan
- Start
- Nov 2011
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of yhd001 in asthma (4 arms), sponsored by Yuhan. Primary endpoint: Change from baseline of Forced Expiratory Volume in 1 second at 4 weeks. Started Nov 2011; status: completed.
02
Drugs
yhd001
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01424124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01424124.